Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French look into safety of dental amalgam:

This article was originally published in Clinica

Executive Summary

A dental amalgam working group has been set up alongside the national vigilance commission at the French healthcare products safety agency (AFSSAPS). Its remit will be to: report on current research concerning the safety of dental amalgam; and propose an information site and recommendations for people who consider that they have suffered medically as a result of noxious effects of dental amalgam. The group is being set up for a year initially, and its work will remain confidential. France banned all dental amalgams, with the exception of pre-dosed capsules, in May 2001 (see Clinica No 959, p 3) because of concerns of mercury overdosage from dental amalgams prepared with the use of metal alloys and mercury.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel